|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$50,630.76 |
2.68% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$49,157.03 |
2.60% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$49,144.26 |
2.60% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$46,591.14 |
2.47% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$45,908.78 |
2.43% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$45,371.22 |
2.40% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$45,014.04 |
2.38% |
| Waters Corporation |
WAT |
941848103 |
123 |
$44,671.14 |
2.37% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$44,365.02 |
2.35% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$43,873.80 |
2.32% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$43,419.90 |
2.30% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$42,807.79 |
2.27% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$42,921.39 |
2.27% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$42,307.28 |
2.24% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$41,213.69 |
2.18% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$41,032.41 |
2.17% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$40,149.79 |
2.13% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$39,095.61 |
2.07% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$38,703.50 |
2.05% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$38,586.24 |
2.04% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$38,081.16 |
2.02% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$37,894.55 |
2.01% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$38,011.41 |
2.01% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$38,001.46 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$37,686.45 |
2.00% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$37,364.88 |
1.98% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$37,207.74 |
1.97% |
| Steris Plc |
STE |
G8473T100 |
177 |
$36,833.70 |
1.95% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$36,192.75 |
1.92% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$36,313.15 |
1.92% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$36,089.96 |
1.91% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$35,845.74 |
1.90% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$35,825.44 |
1.90% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$35,677.39 |
1.89% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$35,429.41 |
1.88% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$35,174.10 |
1.86% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$34,954.64 |
1.85% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$34,411.84 |
1.82% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$34,302.88 |
1.82% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$33,990.90 |
1.80% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$33,778.41 |
1.79% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$33,436.62 |
1.77% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$33,294.04 |
1.76% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$31,672.62 |
1.68% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$30,792.58 |
1.63% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$30,700.44 |
1.63% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$30,142.00 |
1.60% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$29,936.38 |
1.59% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$23,633.33 |
1.25% |
| US Dollar |
$USD |
|
9,464 |
$9,464.24 |
0.50% |
| Japanese Yen |
$JPY |
|
91,571 |
$570.29 |
0.03% |
| Euro |
$EUR |
|
358 |
$412.70 |
0.02% |
| Hong Kong Dollar |
$HKD |
|
0 |
$0.00 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|